HSD17B1

Gene Information
 
Gene Symbol
HSD17B1
 
Aliases
17-beta-HSD, 20-alpha-HSD, E2DH, EDH17B2, EDHB17, HSD17, SDR28C1
 
Entrez Gene ID
 
Gene Name
Hydroxysteroid 17-beta dehydrogenase 1
 
Chromosomal Location
17q21.2
 
HGNC ID
 
Summary
This gene encodes a member of the 17beta-hydroxysteroid dehydrogenase family of short-chain dehydrogenases/reductases. It has a dual function in estrogen activation and androgen inactivation and plays a major role in establishing the estrogen E2 concentration gradient between serum and peripheral tissues. The encoded protein catalyzes the last step in estrogen activation, using NADPH to convert estrogens E1 and E2 and androgens like 4-androstenedione, to testosterone. It has an N-terminal short-chain dehydrogenase domain with a cofactor binding site, and a narrow, hydrophobic C-terminal domain with a steroid substrate binding site. This gene is expressed primarily in the placenta and ovarian granulosa cells, and to a lesser extent, in the endometrium, adipose tissue, and prostate. Polymorphisms in this gene have been linked to breast and prostate cancer. A pseudogene of this gene has been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0006694 Biological process Steroid biosynthetic process TAS 8547176
GO:0008210 Biological process Estrogen metabolic process TAS 2584224
GO:0005737 Cellular component Cytoplasm TAS 8547176
GO:0003824 Molecular function Catalytic activity TAS 8547176
GO:0004303 Molecular function Estradiol 17-beta-dehydrogenase activity IDA 4396689, 9525918, 10625652
Protein Information
 
Protein Name
Estradiol 17-beta-dehydrogenase 1, 17-beta-HSD 1, 17-beta-hydroxysteroid dehydrogenase type 1, 20 alpha-hydroxysteroid dehydrogenase, placental 17-beta-hydroxysteroid dehydrogenase, short chain dehydrogenase/reductase family 28C member 1, short chain dehydrogenase/reductase family 28CE, member 1
 
Function
Favors the reduction of estrogens and androgens. Also has 20-alpha-HSD activity. Uses preferentially NADH
 
UniProt
 
PDB
 
Pfam
Pfam Accession Pfam ID
PF00106 adh_short
Pathways
 
KEGG
 
Reactome
 

Steroid hormone biosynthesis
Metabolic pathways
Ovarian steroidogenesis

 

Estrogen biosynthesis

Interactions
 
STRING MINT IntAct
ENSP00000466799 P14061
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Endocrine System Diseases
PCOS
Immune System Diseases
Autoimmune Diabetes
Neoplasms
Breast Cancer
Lung Cancer
Liver Cancer
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
 
PCOS, Lipid metabolism, Steroidogenesis and follicular growth 
 
 
Direct 
39 PCOS subjects and 30 PCOS controls 
The present study discloses decrease in insulin signaling proteins related to metabolism, lipogenic genes and steroidogenesis in PCOS-IR group as against decrease only in steroidogenesis in PCOS-NIR group. These differential signaling molecules ultimately might be involved in the prevalence of hyperinsulinemia and hyperandrogenemia in PCOS-IR group and intrinsic ovarian defects in PCOSNIR group leading to follicular arrest, poor oocyte growth as well as quality observed in different PCOS phenotypes. The study would aid in designing candidate molecules for targeted therapy towards the two different types of PCOS thus decreasing probability of reproductive failures. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412